Dr. Balestrieri is the innovative mind behind this groundbreaking technology, bringing over 20 years of in-depth expertise in macrophage biology and airway inflammation. Currently, she is a faculty member in the Division of Allergy and Clinical Immunology at Brigham and Women’s Hospital, where she continues to influence cutting-edge research and clinical practice.

Former Harvard Medical School Faculty & LMU Munich faculty. 25+ yrs gene/cell-therapy translation; runs a CRO that delivers IND-enabling packages (biodistribution, dosing, safety/tox, efficacy). Biotech founder/CEO; academia-to-biotech transition specialist.

Dr. Bankova is currently a faculty member in the Division of Allergy and Clinical Immunology at Brigham and Women’s Hospital. Dr. Bankova’s clinical interests include allergic inflammatory diseases, particularly those affecting olfactory function, such as chronic rhinosinusitis, allergic rhinitis, asthma, and anaphylaxis.